ArticleJournal of gastrointestinal oncology2025
"Budding"-an early MRI feature established in a case-control study of perianal fistula mucinous adenocarcinoma.
Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Malignant Transformation of Perianal Fistulas: A Systematic Review of the Literature.Journal of surgical oncology · 2026Pooled it
- Imaging manifestations of malignancy in inflammatory bowel disease: patterns, pitfalls and pearls.Abdominal radiology (New York) · 2026Review
- Oncologic pitfalls and mimics in the abdomen and pelvis.Abdominal radiology (New York) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Perianal fistula mucinous adenocarcinoma (FMA) usually presents at an advanced stage, necessitating extensive surgical resection. Symptoms of perianal pain and discharge are indistinguishable from fistula sepsis. Absence of defined features on magnetic resonance imaging (MRI) precludes early diagnosis. This study aims to validate MRI features that should increase suspicion of early mucinous transformation, prompting urgent examination and targeted biopsies. Methods: Retrospective review of MRI studies was conducted in 9 patients with FMA in Crohn's perianal and non-Crohn's ileoanal pouch fistula between 2015-2019. Radiological features were assessed. Fine T2-weighted high signal lobulation of the fistula tract on MRI, described as 'budding', was retrospectively noted on historic studies in all cases of FMA and was determined a feature distinct from expected T2-weighted high signal appearance of bland fistula sepsis. The significance of these features in early diagnosis of FMA was assessed using a case control study. Results: 'Budding', mass-like expansion of the tract, and septation of T2-weighted high signal components of the fistula were significantly associated with FMA using Fisher's exact test (P<0.001). The presence of T2-weighted high signal "budding" predated the histological confirmation of FMA by a median 36 months (range, 12-156 months). One control patient was diagnosed with FMA during the study as 'budding' was retrospectively detected, triggering urgent targeted biopsy. Conclusions: Radiological awareness of early features of FMA may improve outcomes by reducing the morbidity of exenterative surgery with delayed diagnosis. The presence of T2-weighted high signal 'budding' on MRI should prompt urgent targeted biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.